2021 ASCO Virtual Direct™ Highlights


 

2021 ASCO Updates on EBC: Olaparib in gBRCA1/2m HER2- Disease, Capecitabine vs. Platinum Chemo for TNBC, Neoadjuvant Trastuzumab/Pertuzumab +/- Taxane for HER2+ BC

122 views
August 19, 2021
0 Comments
Login to view comments. Click here to Login